Abstract 2169: TTK/PLK1 dual antagonist BAL0891 synergizes with pembrolizumab in a vascularized 3D tumor microenvironment model
Year: 2025
Type: conference-abstract
Source: Cancer Research
Institution: SillaJen (United States)
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4409628084
